Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
cyproteroneacetat/etinylestradiol alvogen (cypretyl) húðuð tafla 2/0,035 mg
alvogen ehf. - ethinylestradiolum inn; cyproteronum acetat - húðuð tafla - 2/0,035 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
asubtela (ethinylestradiol/drospirenon 0,03 mg/3 mg focus) filmuhúðuð tafla 3 mg/ 0,03 mg
exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
vagidonna leggangatafla 10 míkróg
sandoz a/s* - estradiol - leggangatafla - 10 míkróg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
estrogel hlaup 0,6 mg/g
besins healthcare ireland limited - estradiol - hlaup - 0,6 mg/g
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
trisekvens filmuhúðuð tafla
novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
femanest tafla 1 mg
viatris aps - estradiol - tafla - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
femanest tafla 2 mg
viatris aps - estradiol - tafla - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
estring leggangainnlegg 7,5 míkróg/24 klst.
pfizer aps - estradiol - leggangainnlegg - 7,5 míkróg/24 klst.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hinsveiflur og heilahimnubólur og hliðstæður - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
novofem filmuhúðuð tafla
novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla